Category: Disorders & Diseases

Disorders & Diseases

Respiratory Biologics Have Significantly Reduced Asthma Exacerbations

A large-scale study finds that the introduction of asthma biologics in 2015 has led to immediate and sustained reductions in exacerbations at the population level.

Disorders & Diseases

Microneedle Patch for Peanut Allergies Begins Clinical Trials

A phase 1 study is testing the safety of a microneedle device designed to deliver peanut protein through the skin for desensitization.

Disorders & Diseases

Lung Cancer Survival Rates ‘Improving for Everyone,’ National Report Reveals

The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.

Chronic Pulmonary Disorders

Alpha-1 Antitrypsin Deficiency Drug Enters Ph3 Trial

Grifols enrolled the first patient in its Phase 3 SWIFT-SC clinical trial to evaluate its subcutaneous Alpha1-Proteinase Inhibitor for the treatment of alpha1-antitrypsin (AAT) deficiency.

Infectious Diseases

RSV Antiviral Zelicapavir Enters Late-stage Clinical Trials

Enanta Pharma advanced zelicapavir into a registrational Phase 2b/3 clinical trial for adults at high risk of severe RSV outcomes.

Critical Care

Football vs Fútbol: Which Youth Sport Leads to More Emergency Visits?

A 10-year analysis of emergency department data shows one sport poses a greater risk of severe injury to youth athletes.

Cardiopulmonary & Thoracic

Single-Port Robotic Surgery for Lung Cancer Patients

UT Southwestern Medical Center is the first healthcare provider in North Texas to offer single-port robotic-assisted thoracoscopic lobectomy, a minimally invasive procedure for select patients with early-stage lung cancer.

Sleep Medicine

Monash, Brigham and Women’s Renew Sleep Research Partnership

The collaboration will focus on sleep and circadian medicine, including research into obstructive sleep apnea and wearable health technology.